UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 537

Sortiert nach

Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153

Journal of clinical oncology, 2020-11, Vol.38 (33), p.3863-3873

2020

Volltextzugriff (PDF)

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer

Journal of clinical oncology, 2016-08, Vol.34 (23), p.2712-2720

2016

Volltextzugriff (PDF)

2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting

Supportive care in cancer, 2017-01, Vol.25 (1), p.303-308

2017

Volltextzugriff (PDF)

Curing Metastatic Testicular Cancer

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (7), p.4592-4595

Einhorn, Lawrence H.

2002

Volltextzugriff (PDF)

High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors

The New England journal of medicine, 2007-07, Vol.357 (4), p.340-348

2007

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study

Journal of clinical oncology, 2012-11, Vol.30 (32), p.3998-4003

2012

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3388-3404

2010

Volltextzugriff (PDF)

Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer

Clinical cancer research, 2017-10, Vol.23 (19), p.5757-5768

2017

Volltextzugriff (PDF)

Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission?

Journal of clinical oncology, 2010-02, Vol.28 (4), p.531-536

2010

Volltextzugriff (PDF)

Testicular cancer: a reflection on 50 years of discovery

Journal of clinical oncology, 2014-10, Vol.32 (28), p.3085-3092

2014

Volltextzugriff (PDF)

Testicular Cancer — Discoveries and Updates

The New England journal of medicine, 2014-11, Vol.371 (21), p.2005-2016

2014

Volltextzugriff (PDF)

Randomized Pilot Trial of a Telephone Symptom Management Intervention for Symptomatic Lung Cancer Patients and Their Family Caregivers

Journal of pain and symptom management, 2016-10, Vol.52 (4), p.469-482

2016

Volltextzugriff (PDF)

Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors

Clinical cancer research, 2020-12, Vol.26 (24), p.6550-6558

2020

Volltextzugriff (PDF)

Testicular Cancer: Biology to Bedside

Cancer research (Chicago, Ill.), 2021-11, Vol.81 (21), p.5369-5376

2021

Volltextzugriff (PDF)

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors

Investigational new drugs, 2021-12, Vol.39 (6), p.1656-1663

2021

Volltextzugriff (PDF)

Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine

Oncotarget, 2017-01, Vol.8 (2), p.2949-2959

2017

Volltextzugriff (PDF)

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

Journal of clinical oncology, 2001-06, Vol.19 (11), p.2875-2882

2001

Volltextzugriff (PDF)

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

Oncotarget, 2016-08, Vol.7 (35), p.56491-56500

2016

Volltextzugriff (PDF)

Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy

Journal of cancer survivorship, 2023-02, Vol.17 (1), p.27-39

2023

Volltextzugriff (PDF)

Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2006-09, Vol.24 (27), p.4405-4411

2006

Volltextzugriff (PDF)

The “growing teratoma syndrome” in primary mediastinal nonseminomatous germ cell tumors: Criteria based on current practice

The Journal of thoracic and cardiovascular surgery, 2012-08, Vol.144 (2), p.438-443

2012

Volltextzugriff (PDF)

Barriers to mental health service use and preferences for addressing emotional concerns among lung cancer patients

Psycho-oncology (Chichester, England), 2014-07, Vol.23 (7), p.812-819

2014

Volltextzugriff (PDF)

High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1096-1102

2017

Volltextzugriff (PDF)

Extragonadal germ cell tumors: clinical presentation and management

Current opinion in oncology, 2013-05, Vol.25 (3), p.261-265

2013

Volltextzugriff (PDF)

Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy

Cancer medicine (Malden, MA), 2022-07, Vol.11 (14), p.2801-2816

2022

Volltextzugriff (PDF)

1 – 25 von 537

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(513)
Mit Volltextzugriff
(440)

Publikationsform

Sprache

Englisch
(536)
Japanisch
(62)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(330)
Humans
(326)
Life Sciences & Biomedicine
(325)
Male
(263)
Oncology
(235)
Adult
(183)
Middle Aged
(144)
Biological And Medical Sciences
(138)
Medical Sciences
(138)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(111)
Testicular Neoplasms - Drug Therapy
(98)
Female
(93)
Chemotherapy
(86)
Adolescent
(79)
Aged
(78)
Cisplatin - Administration & Dosage
(72)
Tumors
(72)
Pharmacology. Drug Treatments
(67)
Testicular Neoplasms - Pathology
(65)
Retrospective Studies
(61)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer

2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting

Curing Metastatic Testicular Cancer

High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors

American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors

Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer

Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission?

Testicular cancer: a reflection on 50 years of discovery

Testicular Cancer — Discoveries and Updates

Randomized Pilot Trial of a Telephone Symptom Management Intervention for Symptomatic Lung Cancer Patients and Their Family Caregivers

Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors

Testicular Cancer: Biology to Bedside

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors

Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy

Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

The “growing teratoma syndrome” in primary mediastinal nonseminomatous germ cell tumors: Criteria based on current practice

Barriers to mental health service use and preferences for addressing emotional concerns among lung cancer patients

High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience

Extragonadal germ cell tumors: clinical presentation and management

Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy

Suchergebnisse filtern